Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | PRKCA | P17252 | 1/20 | 0.34 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.34 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.34 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | HTR1B | P28222 | 1/20 | 0.34 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17086056 | 0.93 | KMT2A (0.44) | KMT2ASMN1; SMN2MAPTMAPK1LMNA | |
| SCHEMBL17083878 | 0.93 | KMT2A (0.37) | KMT2ASMN1; SMN2MAPTMAPK1LMNA | |
| SCHEMBL17083849 | 0.92 | KMT2A (0.39) | KMT2ASMN1; SMN2NPC1RAB9ACA2 | |
| SCHEMBL17083869 | 0.91 | PRKCA (0.39) | KMT2ASMN1; SMN2MAPTALDH1A1CNR2 | |
| SCHEMBL17083819 | 0.89 | ALDH1A1 (0.38) | MAPTMAPK1LMNAALDH1A1CNR2 | |
| SCHEMBL17083813 | 0.87 | TLR2 (0.41) | LMNAALDH1A1CNR2PRKCAPRKCE | |
| SCHEMBL17083832 | 0.87 | TLR2 (0.40) | LMNAALDH1A1CNR2PRKCAPRKCE | |
| SCHEMBL17083871 | 0.86 | KMT2A (0.39) | KMT2ASMN1; SMN2MAPTLMNAALDH1A1 | |
| SCHEMBL17083861 | 0.86 | KMT2A (0.38) | KMT2ASMN1; SMN2MAPTLMNAALDH1A1 | |
| SCHEMBL17086055 | 0.85 | KMT2A (0.41) | KMT2ASMN1; SMN2MAPTMAPK1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9328192-B2 | Bio-based monomers and polymers | BEZWADA BIOMEDICAL, LLC (US) | 2016-05-03 | — | — | US | disclosed |
| US-20150259464-A1 | BIO-BASED MONOMERS AND POLYMERS | BEZWADA BIOMEDICAL, LLC | 2015-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150259464-A1 | BIO-BASED MONOMERS AND POLYMERS | FHIT, MGAM, BPGM | KMT2A 4052/4885SMN1; SMN2 4223/4885MAPT 2608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.